5 insiders reported 17 Form 4 transactions for Sagimet Biosciences Inc. (SGMT) over the past 18 months (most recent 2026-02-20). Recent activity: Happel David (President & CEO) Buy 128,000 shares, Rozek Elizabeth (Chief Legal & Admin. Officer) Buy 44,000 shares, Martins Eduardo Bruno (Chief Medical Officer) Buy 44,000 shares, Chauche Thierry (Chief Financial Officer) Buy 44,000 shares, Happel David (President & CEO) Sell 12,101 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | Happel David | President & CEO | Buy | 128,000 | $0 |
| 2026-02-20 | Rozek Elizabeth | Chief Legal & Admin. Officer | Buy | 44,000 | $0 |
| 2026-02-20 | Martins Eduardo Bruno | Chief Medical Officer | Buy | 44,000 | $0 |
| 2026-02-20 | Chauche Thierry | Chief Financial Officer | Buy | 44,000 | $0 |
| 2026-02-12 | Happel David | President & CEO | Sell | 12,101 | $64,861 |
| 2026-02-12 | Martins Eduardo Bruno | Chief Medical Officer | Sell | 3,640 | $19,510 |
| 2026-02-12 | Rozek Elizabeth | Chief Legal & Admin. Officer | Sell | 2,622 | $14,054 |
| 2026-02-12 | Chauche Thierry | Chief Financial Officer | Sell | 1,312 | $7,032 |
| 2025-11-21 | Kemble George | Executive Chairman | Sell | 37,688 | $289,821 |
| 2025-11-06 | Rozek Elizabeth | Chief Legal & Admin. Officer | Buy | 9,855 | $0 |
| 2025-07-23 | Happel David | President & CEO | Sell | 65,478 | $597,814 |
| 2025-07-23 | Rozek Elizabeth | General Counsel and CCO | Sell | 10,780 | $98,421 |
| 2025-07-23 | Martins Eduardo Bruno | Chief Medical Officer | Sell | 8,277 | $75,569 |
| 2025-02-07 | Happel David | President & CEO | Buy | 116,000 | $0 |
| 2025-02-07 | Chauche Thierry | Chief Financial Officer | Buy | 17,000 | $0 |
| 2025-02-07 | Rozek Elizabeth | General Counsel and CCO | Buy | 34,000 | $0 |
| 2025-02-07 | Martins Eduardo Bruno | Chief Medical Officer | Buy | 34,000 | $0 |
Source: SEC Form 4 filings · as of 2026-02-20